Details for Patent: 11,554,229
Which drugs does patent 11,554,229 protect, and when does it expire?
Patent 11,554,229 protects XHANCE and is included in one NDA.
This patent has forty-three patent family members in seventeen countries.
Summary for Patent: 11,554,229
| Title: | Nasal administration |
| Abstract: | A method of delivering a substance, such as one or more of a triptan, a nasal steroid or carbon dioxide gas, to the nasal cavity of a subject, in particular for the treatment of headaches, for example, migraine, or rhinosinusitis, for example, chronic rhinosinusitis, optionally with polyps, the method comprising the steps of fitting a nosepiece to one nostril of the subject, delivering the substance through the nosepiece to the posterior region of the nasal cavity of the subject. |
| Inventor(s): | Per Gisle Djupesland, Ramy A. Mahmoud, John Messina |
| Assignee: | Optinose Inc |
| Application Number: | US14/315,132 |
|
Patent Claim Types: see list of patent claims | Use; Delivery; |
Drugs Protected by US Patent 11,554,229
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Paratek Pharms | XHANCE | fluticasone propionate | SPRAY, METERED;NASAL | 209022-001 | Sep 18, 2017 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | METHOD OF DELIVERING FLUTICASONE PROPIONATE TO A NASAL AIRWAY | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,554,229
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2014242658 | ⤷ Start Trial | |||
| Australia | 2015279154 | ⤷ Start Trial | |||
| Australia | 2019200191 | ⤷ Start Trial | |||
| Australia | 2020202029 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
